annual cost of goods sold:
$10.21B+$1.94B(+23.45%)Summary
- As of today (May 29, 2025), AZN annual cost of goods sold is $10.21 billion, with the most recent change of +$1.94 billion (+23.45%) on December 31, 2024.
- During the last 3 years, AZN annual cost of goods sold has fallen by -$2.23 billion (-17.93%).
- AZN annual cost of goods sold is now -17.93% below its all-time high of $12.44 billion, reached on December 31, 2021.
Performance
AZN Cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cost of goods sold:
$2.24B-$484.00M(-17.76%)Summary
- As of today (May 29, 2025), AZN quarterly cost of goods sold is $2.24 billion, with the most recent change of -$484.00 million (-17.76%) on March 31, 2025.
- Over the past year, AZN quarterly cost of goods sold has increased by +$23.00 million (+1.04%).
- AZN quarterly cost of goods sold is now -51.55% below its all-time high of $4.63 billion, reached on December 31, 2021.
Performance
AZN quarterly cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM cost of goods sold:
$10.23B+$23.00M(+0.23%)Summary
- As of today (May 29, 2025), AZN TTM cost of goods sold is $10.23 billion, with the most recent change of +$23.00 million (+0.23%) on March 31, 2025.
- Over the past year, AZN TTM cost of goods sold has increased by +$1.65 billion (+19.22%).
- AZN TTM cost of goods sold is now -31.30% below its all-time high of $14.89 billion, reached on June 30, 2022.
Performance
AZN TTM cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cost of goods sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
AZN Cost of goods sold Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +23.4% | +1.0% | +19.2% |
3 y3 years | -17.9% | -36.2% | -27.4% |
5 y5 years | +107.4% | +57.8% | +96.3% |
AZN Cost of goods sold Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -17.9% | +23.4% | -36.2% | +17.6% | -31.3% | +23.7% |
5 y | 5-year | -17.9% | +107.4% | -51.5% | +127.7% | -31.3% | +99.3% |
alltime | all time | -17.9% | +402.6% | -51.5% | +633.6% | -31.3% | +1139.3% |
AZN Cost of goods sold History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $2.24B(-17.8%) | $10.23B(+0.2%) |
Dec 2024 | $10.21B(+23.5%) | $2.73B(-11.6%) | $10.21B(+4.3%) |
Sep 2024 | - | $3.08B(+41.1%) | $9.79B(+11.2%) |
Jun 2024 | - | $2.18B(-1.6%) | $8.80B(+2.6%) |
Mar 2024 | - | $2.22B(-3.9%) | $8.58B(+3.8%) |
Dec 2023 | $8.27B(-33.3%) | $2.31B(+10.2%) | $8.27B(-6.7%) |
Sep 2023 | - | $2.10B(+6.9%) | $8.86B(-9.1%) |
Jun 2023 | - | $1.96B(+2.9%) | $9.75B(-9.6%) |
Mar 2023 | - | $1.91B(-34.3%) | $10.79B(-13.0%) |
Dec 2022 | $12.39B(-0.4%) | $2.90B(-2.7%) | $12.39B(-12.2%) |
Sep 2022 | - | $2.98B(-0.5%) | $14.12B(-5.2%) |
Jun 2022 | - | $3.00B(-14.6%) | $14.89B(+5.7%) |
Mar 2022 | - | $3.51B(-24.1%) | $14.08B(+13.2%) |
Dec 2021 | $12.44B(+134.7%) | $4.63B(+23.1%) | $12.44B(+33.2%) |
Sep 2021 | - | $3.76B(+71.5%) | $9.34B(+34.3%) |
Jun 2021 | - | $2.19B(+17.5%) | $6.95B(+21.0%) |
Mar 2021 | - | $1.86B(+22.2%) | $5.74B(+8.4%) |
Dec 2020 | $5.30B(+7.7%) | $1.52B(+11.3%) | $5.30B(+2.9%) |
Sep 2020 | - | $1.37B(+39.2%) | $5.15B(+0.4%) |
Jun 2020 | - | $984.00M(-30.7%) | $5.13B(-1.5%) |
Mar 2020 | - | $1.42B(+3.0%) | $5.21B(+5.9%) |
Dec 2019 | $4.92B(-0.3%) | $1.38B(+2.0%) | $4.92B(-5.0%) |
Sep 2019 | - | $1.35B(+27.1%) | $5.18B(+4.0%) |
Jun 2019 | - | $1.06B(-5.8%) | $4.98B(+1.0%) |
Mar 2019 | - | $1.13B(-31.0%) | $4.93B(-0.1%) |
Dec 2018 | $4.94B(+14.3%) | $1.64B(+42.0%) | $4.94B(+9.1%) |
Sep 2018 | - | $1.15B(+13.9%) | $4.52B(-2.1%) |
Jun 2018 | - | $1.01B(-10.8%) | $4.62B(+1.4%) |
Mar 2018 | - | $1.13B(-7.4%) | $4.56B(+5.6%) |
Dec 2017 | $4.32B(+4.7%) | $1.23B(-1.9%) | $4.32B(+1.5%) |
Sep 2017 | - | $1.25B(+31.5%) | $4.25B(+8.9%) |
Jun 2017 | - | $950.00M(+6.3%) | $3.90B(-2.8%) |
Mar 2017 | - | $894.00M(-22.9%) | $4.02B(-2.7%) |
Dec 2016 | $4.13B(-11.2%) | $1.16B(+28.9%) | $4.13B(-2.6%) |
Sep 2016 | - | $900.00M(-15.3%) | $4.24B(-3.2%) |
Jun 2016 | - | $1.06B(+5.8%) | $4.38B(-0.1%) |
Mar 2016 | - | $1.00B(-20.9%) | $4.38B(-5.7%) |
Dec 2015 | $4.65B(-20.5%) | $1.27B(+21.9%) | $4.65B(-7.9%) |
Sep 2015 | - | $1.04B(-2.4%) | $5.04B(-6.9%) |
Jun 2015 | - | $1.07B(-15.9%) | $5.42B(-4.2%) |
Mar 2015 | - | $1.27B(-23.9%) | $5.66B(-3.1%) |
Dec 2014 | $5.84B(+11.0%) | $1.67B(+17.8%) | $5.84B(+4.0%) |
Sep 2014 | - | $1.42B(+8.3%) | $5.62B(+3.3%) |
Jun 2014 | - | $1.31B(-10.0%) | $5.44B(-0.2%) |
Mar 2014 | - | $1.45B(+0.9%) | $5.45B(+3.6%) |
Dec 2013 | $5.26B(-2.4%) | $1.44B(+16.3%) | $5.26B(+0.8%) |
Sep 2013 | - | $1.24B(-6.0%) | $5.22B(-0.7%) |
Jun 2013 | - | $1.32B(+4.0%) | $5.25B(-0.5%) |
Mar 2013 | - | $1.27B(-9.4%) | $5.28B(-2.0%) |
Dec 2012 | $5.39B(-10.5%) | $1.40B(+9.7%) | $5.39B(-3.8%) |
Sep 2012 | - | $1.27B(-5.3%) | $5.61B(-5.4%) |
Jun 2012 | - | $1.35B(-2.1%) | $5.93B(-2.2%) |
Mar 2012 | - | $1.38B(-14.7%) | $6.06B(+0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $6.03B(-5.7%) | $1.61B(+1.2%) | $6.03B(-2.4%) |
Sep 2011 | - | $1.59B(+7.5%) | $6.17B(+1.1%) |
Jun 2011 | - | $1.48B(+10.7%) | $6.10B(+0.5%) |
Mar 2011 | - | $1.34B(-23.9%) | $6.07B(-4.9%) |
Dec 2010 | $6.39B(+10.6%) | $1.76B(+15.4%) | $6.39B(+1.5%) |
Sep 2010 | - | $1.52B(+5.0%) | $6.29B(+4.3%) |
Jun 2010 | - | $1.45B(-12.2%) | $6.03B(-0.2%) |
Mar 2010 | - | $1.65B(-0.7%) | $6.05B(+4.7%) |
Dec 2009 | $5.78B(-12.5%) | $1.67B(+31.8%) | $5.78B(-7.2%) |
Sep 2009 | - | $1.26B(-13.7%) | $6.22B(-4.9%) |
Jun 2009 | - | $1.46B(+5.9%) | $6.54B(+0.5%) |
Mar 2009 | - | $1.38B(-34.5%) | $6.51B(-1.3%) |
Dec 2008 | $6.60B(+2.8%) | $2.11B(+33.2%) | $6.60B(-0.4%) |
Sep 2008 | - | $1.58B(+10.8%) | $6.63B(+2.8%) |
Jun 2008 | - | $1.43B(-2.7%) | $6.45B(-0.6%) |
Mar 2008 | - | $1.47B(-31.3%) | $6.49B(+1.0%) |
Dec 2007 | $6.42B(+15.5%) | $2.14B(+52.4%) | $6.42B(+9.6%) |
Sep 2007 | - | $1.41B(-4.4%) | $5.86B(+1.1%) |
Jun 2007 | - | $1.47B(+4.6%) | $5.79B(+2.3%) |
Mar 2007 | - | $1.40B(-11.0%) | $5.66B(+1.8%) |
Dec 2006 | $5.56B(+3.8%) | $1.58B(+17.8%) | $5.56B(+3.5%) |
Sep 2006 | - | $1.34B(+0.1%) | $5.37B(+1.8%) |
Jun 2006 | - | $1.34B(+2.5%) | $5.28B(+0.5%) |
Mar 2006 | - | $1.30B(-6.0%) | $5.25B(-2.0%) |
Dec 2005 | $5.36B(+3.1%) | $1.39B(+11.5%) | $5.36B(-2.0%) |
Sep 2005 | - | $1.25B(-5.2%) | $5.47B(-0.7%) |
Jun 2005 | - | $1.31B(-6.9%) | $5.51B(+1.1%) |
Mar 2005 | - | $1.41B(-5.9%) | $5.45B(+4.9%) |
Dec 2004 | $5.19B(+16.4%) | $1.50B(+16.5%) | $5.19B(+9.4%) |
Sep 2004 | - | $1.29B(+2.8%) | $4.75B(+2.5%) |
Jun 2004 | - | $1.25B(+8.0%) | $4.63B(+3.2%) |
Mar 2004 | - | $1.16B(+10.2%) | $4.48B(+0.5%) |
Dec 2003 | $4.46B(-1.3%) | $1.05B(-10.1%) | $4.46B(+0.1%) |
Sep 2003 | - | $1.17B(+5.6%) | $4.46B(-3.2%) |
Jun 2003 | - | $1.11B(-2.7%) | $4.61B(+1.0%) |
Mar 2003 | - | $1.14B(+8.5%) | $4.56B(+0.9%) |
Dec 2002 | $4.52B(+1.4%) | $1.05B(-20.5%) | $4.52B(-3.4%) |
Sep 2002 | - | $1.32B(+24.4%) | $4.68B(+5.7%) |
Jun 2002 | - | $1.06B(-3.1%) | $4.42B(-1.2%) |
Mar 2002 | - | $1.09B(-9.3%) | $4.48B(+0.5%) |
Dec 2001 | $4.46B(+37.2%) | $1.21B(+13.3%) | $4.45B(+37.1%) |
Sep 2001 | - | $1.06B(-4.3%) | $3.25B(+3.5%) |
Jun 2001 | - | $1.11B(+3.9%) | $3.14B(+3.2%) |
Mar 2001 | - | $1.07B(+12.1%) | $3.04B(+16.0%) |
Sep 2000 | - | $955.16M(-5.8%) | $2.62B(-10.2%) |
Jun 2000 | - | $1.01B(-5.3%) | $2.92B(-6.2%) |
Mar 2000 | - | $1.07B(-354.9%) | $3.11B(+52.5%) |
Dec 1999 | $3.25B(+59.9%) | -$420.00M(-133.5%) | $2.04B(-17.1%) |
Sep 1999 | - | $1.25B(+3.8%) | $2.46B(+103.8%) |
Jun 1999 | - | $1.21B(+46.3%) | $1.21B(+46.3%) |
Dec 1998 | $2.03B | - | - |
Jun 1998 | - | $825.50M(-12.9%) | $825.50M(-12.9%) |
Jun 1995 | - | $947.90M | $947.90M |
FAQ
- What is AstraZeneca annual cost of goods sold?
- What is the all time high annual cost of goods sold for AstraZeneca?
- What is AstraZeneca annual cost of goods sold year-on-year change?
- What is AstraZeneca quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for AstraZeneca?
- What is AstraZeneca quarterly cost of goods sold year-on-year change?
- What is AstraZeneca TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for AstraZeneca?
- What is AstraZeneca TTM cost of goods sold year-on-year change?
What is AstraZeneca annual cost of goods sold?
The current annual cost of goods sold of AZN is $10.21B
What is the all time high annual cost of goods sold for AstraZeneca?
AstraZeneca all-time high annual cost of goods sold is $12.44B
What is AstraZeneca annual cost of goods sold year-on-year change?
Over the past year, AZN annual cost of goods sold has changed by +$1.94B (+23.45%)
What is AstraZeneca quarterly cost of goods sold?
The current quarterly cost of goods sold of AZN is $2.24B
What is the all time high quarterly cost of goods sold for AstraZeneca?
AstraZeneca all-time high quarterly cost of goods sold is $4.63B
What is AstraZeneca quarterly cost of goods sold year-on-year change?
Over the past year, AZN quarterly cost of goods sold has changed by +$23.00M (+1.04%)
What is AstraZeneca TTM cost of goods sold?
The current TTM cost of goods sold of AZN is $10.23B
What is the all time high TTM cost of goods sold for AstraZeneca?
AstraZeneca all-time high TTM cost of goods sold is $14.89B
What is AstraZeneca TTM cost of goods sold year-on-year change?
Over the past year, AZN TTM cost of goods sold has changed by +$1.65B (+19.22%)